BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15541753)

  • 1. Target-specific action of organochlorine compounds in reproductive and nonreproductive tissues of estrogen-reporter male mice.
    Villa R; Bonetti E; Penza ML; Iacobello C; Bugari G; Bailo M; Parolini O; Apostoli P; Caimi L; Ciana P; Maggi A; Di Lorenzo D
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):137-48. PubMed ID: 15541753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole body action of xenoestrogens with different chemical structures in estrogen reporter male mice.
    Penza M; Bonetti E; Villa R; Ganzerla S; Bergonzi R; Biasiotto G; Caimi L; Apostoli P; Ciana P; Maggi A; Di Lorenzo D
    Toxicology; 2004 Dec; 205(1-2):65-73. PubMed ID: 15458791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein accumulates in body depots and is mobilized during fasting, reaching estrogenic levels in serum that counter the hormonal actions of estradiol and organochlorines.
    Penza M; Montani C; Romani A; Vignolini P; Ciana P; Maggi A; Pampaloni B; Caimi L; Di Lorenzo D
    Toxicol Sci; 2007 Jun; 97(2):299-307. PubMed ID: 17337754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genistein is an efficient estrogen in the whole-body throughout mouse development.
    Montani C; Penza M; Jeremic M; Biasiotto G; La Sala G; De Felici M; Ciana P; Maggi A; Di Lorenzo D
    Toxicol Sci; 2008 May; 103(1):57-67. PubMed ID: 18281260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isomer-specific activity of dichlorodyphenyltrichloroethane with estrogen receptor in adult and suckling estrogen reporter mice.
    Di Lorenzo D; Villa R; Biasiotto G; Belloli S; Ruggeri G; Albertini A; Apostoli P; Raviscioni M; Ciana P; Maggi A
    Endocrinology; 2002 Dec; 143(12):4544-51. PubMed ID: 12446581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Food-associated estrogenic compounds induce estrogen receptor-mediated luciferase gene expression in transgenic male mice.
    Ter Veld MG; Zawadzka E; van den Berg JH; van der Saag PT; Rietjens IM; Murk AJ
    Chem Biol Interact; 2008 Jul; 174(2):126-33. PubMed ID: 18501883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the organochlorine pesticide DDT and its metabolite p,p'-DDE on p-glycoprotein activity and expression.
    Shabbir A; DiStasio S; Zhao J; Cardozo CP; Wolff MS; Caplan AJ
    Toxicol Appl Pharmacol; 2005 Mar; 203(2):91-8. PubMed ID: 15710169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast-feeding and serum p,p'DDT levels among Mexican women of childbearing age: a pilot study.
    López-Carrillo L; Torres-Sánchez L; Moline J; Ireland K; Wolff MS
    Environ Res; 2001 Dec; 87(3):131-5. PubMed ID: 11771926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
    Fujimoto N; Kitamura S
    J Steroid Biochem Mol Biol; 2004 Jan; 88(1):53-9. PubMed ID: 15026083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free BG-1 cell proliferation assay: a sensitive method for determining organochlorine pesticide estrogen receptor activation at the nanomolar range.
    Wong PS; Matsumura F
    Toxicol In Vitro; 2006 Apr; 20(3):382-94. PubMed ID: 16242299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
    Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenobiotics released from fat during fasting produce estrogenic effects in ovariectomized mice.
    Bigsby RM; Caperell-Grant A; Madhukar BV
    Cancer Res; 1997 Mar; 57(5):865-9. PubMed ID: 9041187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic microenvironment generated by organochlorine residues in adipose mammary tissue modulates biomarker expression in ERalpha-positive breast carcinomas.
    Muñoz-de-Toro M; Durando M; Beldoménico PM; Beldoménico HR; Kass L; García SR; Luque EH
    Breast Cancer Res; 2006; 8(4):R47. PubMed ID: 16859517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different modulation of ER-mediated transactivation by xenobiotic nuclear receptors depending on the estrogen response elements and estrogen target cell types.
    Min G
    Ann N Y Acad Sci; 2006 Dec; 1091():244-57. PubMed ID: 17341619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist.
    Kelce WR; Stone CR; Laws SC; Gray LE; Kemppainen JA; Wilson EM
    Nature; 1995 Jun; 375(6532):581-5. PubMed ID: 7791873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of ERalpha by Rosiglitazone induces proliferation in breast cancer cells.
    Talbert DR; Allred CD; Zaytseva YY; Kilgore MW
    Breast Cancer Res Treat; 2008 Mar; 108(1):23-33. PubMed ID: 17453334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental and hormonal regulation of progesterone receptor A-form expression in female mouse lung in vivo: interaction with glucocorticoid receptors.
    Shao R; Egecioglu E; Weijdegård B; Ljungström K; Ling C; Fernandez-Rodriguez J; Billig H
    J Endocrinol; 2006 Sep; 190(3):857-70. PubMed ID: 17003286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-like effects of diet-derived cadmium differ from those of orally administered CdCl(2) in the ERE-luc estrogen reporter mouse model.
    Ramachandran B; Mäkelä S; Cravedi JP; Berglund M; Håkansson H; Damdimopoulou P; Maggi A
    Toxicol Lett; 2011 Apr; 202(2):75-84. PubMed ID: 21195146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.